Aurinia Pharmaceuticals Inc (AUPH)
Cost of Revenue
$30.04M
TTM · Period ending: · USD

AUPH Cost of Revenue
Latest reported$30.04Mperiod ending
Latest reported$30.04Mperiod ending
AUPH TTM Cost of Revenue ($678.44K → $30.04M)
TTM cost of revenue
High-resolution chart · PNG
AUPH cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 30,036,000 | |
| 30,596,000 | |
| 32,665,000 | |
| 29,745,000 | |
| 27,276,000 | |
| 29,070,000 | |
| 28,248,000 | |
| 28,091,000 | |
| 28,825,000 | |
| 21,479,000 | |
| 14,148,000 | |
| 10,115,000 | |
| 5,793,000 | |
| 5,829,000 | |
| 5,664,000 | |
| 4,783,000 | |
| 2,590,000 | |
| 1,299,000 | |
| 1,091,000 | |
| 610,000 | |
| 356,000 | |
| 48,000 | |
| 0 | |
| 13,292,000 | |
| 31,083,000 | |
| 42,235,000 | |
| 52,866,000 | |
| 50,413,000 | |
| 43,774,000 | |
| 43,126,000 | |
| 41,382,000 | |
| 39,234,000 | |
| 38,889,000 | |
| 35,492,000 | |
| 26,606,000 | |
| 17,916,000 | |
| 7,110,000 | |
| 4,000 | |
| 4,000 | |
| 5,000 | |
| 5,000 | |
| 8,000 | |
| 12,000 | |
| 18,000 | |
| 28,000 | |
| 34,000 | |
| 37,000 | |
| 29,939 | |
| 542,939 | |
| 974,939 | |
| 967,922 | |
| 973,598 | |
| 458,742 | |
| 27,557 | |
| 45,617 | |
| 52,581 | |
| 55,001 | |
| 59,673 | |
| 195,994 | |
| 191,732 | |
| 188,891 | |
| 178,147 | |
| 50,250 | |
| 79,808 | |
| 115,990 | |
| 348,121 | |
| 320,654 | |
| 125,892 | |
| 1,887,146 | |
| 1,877,232 | |
| 2,130,802 | |
| 2,656,980 | |
| 1,138,895 | |
| 1,075,392 | |
| 821,822 | |
| 616,980 | |
| 487,422 | |
| 452,308 | |
| 452,308 | |
| 286,859 | |
| 128,343 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 117,664 | |
| 311,734 | |
| 550,441 | |
| 685,245 | |
| 737,294 | |
| 919,804 | |
| 970,052 | |
| 1,052,865 | |
| 1,080,726 |